Topic prioritisation
Showing 381 to 381 of 381
| Title | Prioritisation programme | Decision | Decision date |
|---|---|---|---|
| Vedolizumab for treating moderately to severely active Crohn's disease in people 2 to 17 years [TSID12312] | Medicines evaluation | Awaiting decision | TBC |